JC113 (Paediatrics) - A Jaundiced Child: Neonatal Jaundice Flashcards
Define neonatal jaundice
Define level of bilirubin for jaundice
Prevalence of neonatal jaundice
Neonatal period = first 28 days of life
Jaundice results from bilirubin accumulation in skin and sclera
neonates: jaundice is visible when it reaches 80-100 μmol/L (4.5-6.0 mg/dL)
Clinical jaundice within the first few days of life:
>50% of term infants
80% of preterm infants
Difference between jaundice with yellow color vs jaundice with yellow + green hue
Yellow – unconjugated bilirubin
Yellow with green hue – conjugated bilirubin
Normal physiology of bilirubin processing
heme metabolism:
RBC broken down in reticuloendothelial system:
Heme processed to biliverdin»_space; unconjugated bilirubin»_space; binds to albumin and enters hepatic circulation
Liver: Unconjugated bilirubin processed by UDGPT»_space; conjugated bilirubin
Large intestine: Conjugated bilirubin processed by Intestinal B-glucuronidase»_space; Unconjugated bilirubin for excretion or retenter enterohepatic circulation
Causes of physiological* neonatal jaundice
- Upstream:
- High Hb load in neonates (mean 17-19 g/dL)
- Short RBC lifespan with faster turnover (half-life 80 days) - Downstream: Immature liver metabolic function:
- Low ligandin = low uptake of bilirubin into liver cells
- Low conjugation enzyme activity (UDGPT) = poor conjugation function - Enterohepatic circulation:
- High amount of bilirubin recycled from gut when feeding is minimal in the first 2-3 days of life
Neonatal jaundice
- Typical time span
- Investigations for confirmation
Natural history:
Apparent from day 2-3 of life
Peaks at day 4-5
Subsides by day 7-14
Laboratory tests:
Unconjugated hyperbilirubinemia (commonly >170 umol/L)
Absent/minimal conjugated fraction
Normal hepatic ductal and parenchymal enzymes
Blood smear: no evidence of haemolysis (if yes»_space; watch out for kernicterus)
Severe NNJ (unconjugated hyperbilirubinemia)
main causes
A. Exaggeration of mechanisms responsible for normal neonatal physiologic jaundice
B. Specific underlying pathological conditions:
- Hemolysis of various causes***
- Inadequate feeding (higher enterohepatic circulation)
- Sepsis
C. Breast milk jaundice
Causes of neonatal hemolysis a/w severe NNJ
i. Immune causes, e.g. Rhesus incompatibility (Caucasian), ABO incompatibility
ii. Non-immune, e.g. G6PD deficiency
iii. Extravasation of blood and breakdown e.g. cephalhematoma, intraventricular hemorrhage, birth trauma with extensive bleeding
iv. Polycythemia (high RBC load and breakdown)
Differentiate underlying cause of breastmilk jaundice and breastfeeding jaundice
Breastmilk jaundice:
Certain ingredients in breast milk slow down conjugation e.g. nonesterified long chain fatty acids, glucuronidase, B-diol)
Presentation: more delayed
Breastfeeding jaundice
- Inadequate breastfeeding in first few days of life
- Less bilirubin excretion in stool
- Bilirubin deconjugated by intestinal B-glucuronidase and reabsorbed into blood (Higher enterohepatic circulation)
Presentation: First few days oflife
Breast milk jaundice
- Time span
- Effect on baby’s health
- Ix and Tx
Jaundice may be prolonged (i.e. beyond 14 days of life), even up to 2-3 months old
= benign condition: baby healthy otherwise, thriving
Ix: all unconjugated (do fractional bilirubin – direct and indirect)
Tx: self-limiting, advise mothers to continue breastfeeding
Complication of severe NNJ *****
Presentation in early, late and end-stage
Encephalopathy/ kernicterus:
- Unconjugated bilirubin can cross lipid layers and blood brain barriers
- Cause damage to neural tissue (bilirubin neurotoxicity)
Early: Hypotonia Hypertonia Opisthotonus (like severe tetanus) Poor feeding Lethargy Fever Convulsion
Late:
Extrapyramidal signs (acute dystonia, akathisia, Parkinsonism, tardive dyskinesia)
Hearing loss
End:
Death
Long-term morbidity: Dystonic cerebral palsy, Upward gaze palsy, Hearing loss
Risk factors of severe NNJ/ kernicterus
- Very high unconjugated bilirubin level in blood for a prolonged period
- High “free” bilirubin with insufficient albumin
Low albumin
Competitive binding to albumin (e.g. drugs) - Hemolysis
- Sepsis (albumin = negative acute phase reactant)
- Acidosis
- Hypoglycemia
- Prematurity
Management of severe NNJ and bilirubin toxicity
- Regularly screen for neonatal jaundice in first 2 weeks of life
- Monitor total bilirubin for severity (“free” bilirubin is not readily measurable)
- Intervene before plasma bilirubin reaches “risky” level:
Term: <20mg/dl (340 mol/L)
Preterm: lower
- Phototherapy, Mesoporphyrin, Exchnage transfusion, IvIg - Avoid risk factors for kernicterus: prolong hyperbilirubinemia, low albumin, acidosis, hypoglycemia, sepsis, hemolysis…
Conjugated hyperbilirubinemia in neonate
- Cut-off of bilirubin level
- Associated biochemical derangement
Direct bilirubin:
>2mg/dL (35μmol/L); or
>15% of total serum bilirubin
Associated with other evidence of hepatobiliary disease:
Elevated parenchymal/ductal enzymes
Deranged synthetic functions, e.g. deranged clotting factors, low albumin
Deranged detoxification functions, e.g. hyperammonemia
Deranged metabolic function, e.g. hypoglycemia
Causes of conjugated hyperbilirubinemia in Neonatal period
Neonatal period:
Neonatal hepatitis (etiological agents mostly unknown)
Obstructive: biliary atresia/ choledochal cyst
Metabolic diseases, e.g. citrin deficiency, galactosemia
Prolonged parenteral nutrition associated cholestasis
Syndromal disorders
Neonatal hemochromatosis (rare)
Causes of Conjugated hyperbilirubinemia beyond neonatal period
Viral hepatitis (A-E)
Drug-induced hepatotoxicity (e.g. paracetamol)
Wilson’s disease
Hemochromatosis, other metabolic diseases
Others (e.g. choledochal cyst, hereditary hyperbilirubinemia)
Cystic fibrosis